Crystax Pharmaceuticals, S.L.
Latest round
- Series B
Last raised
- Nov 2007
Total raised
- Undisclosed
Investors
- 3
About Crystax Pharmaceuticals, S.L.
L.L. was founded in 2002 and is headquartered in Barcelona, Spain. The company focuses on providing solutions for the Android development community. In March 2009, Crystax was acquired by Oryzon Genomics.CrystaX specializes in providing the CrystaX NDK, an open-source native development kit designed specifically for Android developers. This toolkit serves as a drop-in replacement for Google's Android NDK, offering enhanced features and compatibility. The CrystaX NDK has been utilized by a variety of commercial and open-source projects since its inception, providing developers with tools to create high-performance Android applications. The primary use cases it addresses include native code integration, improved performance for resource-intensive applications, and streamlined development processes, making it particularly appealing to developers working on complex Android projects.50 mn. The company operates on a revenue model that combines user donations and fundraising campaigns aimed at supporting ongoing development. Revenue from donations is collected voluntarily, allowing developers to contribute based on the perceived value of the CrystaX NDK.L. plans to leverage the resources of Oryzon Genomics for future product development. The company aims to design new features for the CrystaX NDK and expand its presence in emerging markets, focusing on developers in Asia and Latin America by 2010. The recent acquisition provides the capital needed to support these initiatives, ensuring ongoing enhancements to its product offerings.
Who invested in Crystax Pharmaceuticals, S.L.
3 investors across 1 round
See all investors in Crystax Pharmaceuticals, S.L.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 1, 2007
Amount
Undisclosed
Investors
Questions about Crystax Pharmaceuticals, S.L.
Who invested in Crystax Pharmaceuticals, S.L.?
Crystax Pharmaceuticals, S.L. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Crystax Pharmaceuticals, S.L. raised?
Crystax Pharmaceuticals, S.L. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Crystax Pharmaceuticals, S.L. last raise money?
Crystax Pharmaceuticals, S.L.'s most recent round on record is a Series B, in Nov 2007.
What does Crystax Pharmaceuticals, S.L. do?
Crystax Pharmaceuticals, S.L. is a biotechnology company.
Where is Crystax Pharmaceuticals, S.L. headquartered?
Crystax Pharmaceuticals, S.L. is headquartered in Barcelona, Spain.
Which VCs invest in companies like Crystax Pharmaceuticals, S.L.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Crystax Pharmaceuticals, S.L.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Crystax Pharmaceuticals, S.L.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.